Ansari, E.
Chappiti, S.
Pavicic-Astalos, J.
Pinto-Bonilla, J. C.
Riva, I.
Sacchi, M.
Saénz-Francés, F.
Funding for this research was provided by:
Santen SA
Article History
Received: 31 August 2021
Accepted: 20 March 2022
First Online: 2 April 2022
Declarations
:
: Ethics approval has been obtained from institutional review boards, where required locally. Cases included from Complejo Hospitalario de Navarra were approved for publication by the Comité Ético de Investigación Clínica del Complejo Universitario de Navarra. As this was a retrospective case review, ethics approval was not required from the other participating authors/centers.
: Written informed consent was obtained from the patient for publication of case reports and any accompanying images, where required and in line with institutional procedures at each of the centers providing data for this article.
: Ejaz Ansari has received lecturing fees from Santen and Théa.Shankar Chappiti has received lecture fees and educational grant funding from Santen UK, Glaucoma Trainer fees from Novartis UK and lecture fees from Medicom Healthcare UK.Jasna Pavicic-Astalos has received consultancy and lecturing fees from TheaPamex, Santen and Allergan.Juan Carlos Pinto-Bonilla has no relevant financial declarations.Ivano Riva declares honoraria and congress expenses from Allergan, Santen, Visufarma, SOOFT/Glaucoom, SIFI.Matteo Sacchi has no relevant financial declarations.